BioNTech SE

AFRICA — German mRNA vaccine maker BioNTech has joined forces with vaccine manufacturing facilities in Rwanda, Senegal, and South Africa to help the African Union’s…

GERMANY —German biotechnology company BioNTech is currently embroiled in a legal dispute as it faces a lawsuit filed by a German woman who alleges that…

BELGIUM — The European Union (EU) and pharmaceutical companies Pfizer and BioNTech have announced an amendment to their COVID-19 vaccine contract. This revision involves a…

GERMANY — BioNTech has chosen to sever ties with Matinas BioPharma after an oral mRNA delivery technology failed to demonstrate preclinical activity in an initial…

GERMANY — BioNTech has entered into a partnership with DualityBio, a move that will enable both companies to delve into next-generation antibody-drug conjugate (ADC) therapeutics…

GERMANY – BioNTech SE has completed the US$43 million (€40m) construction of its first proprietary plasmid DNA manufacturing facility in Marburg, Germany, to produce an…

GERMANY — BioNTech SE, a German-based immunotherapy company, has agreed to acquire British artificial intelligence (AI) startup InstaDeep for up to 562 million pounds (US$682…

GERMANY – BioNTech SE has signed a collaboration agreement with the Government of the United Kingdom to benefit cancer patients by accelerating clinical trials for…

TAIWAN — Germany’s BioNTech is planning to set up a clinical trial hub in Taiwan for mRNA-based cancer immunotherapies as part of its Asia-Pacific expansion,…